Latest Joint Ventures News

Marmota Limited’s maiden drilling program at Greenewood in South Australia reveals bonanza-grade gold and extensive mineralisation, with follow-up drilling set to expand the discovery further.

FMR Resources has intersected multiple broad mineralised porphyry phases with visible copper and molybdenite at Target K within its Llahuin Project JV in Chile, refining the search for the core mineralised source.

PRL Global Ltd reported a robust half-year performance with revenue soaring 64% to $1.14 billion and net profit rising 71%, driven by a strategic acquisition and operational growth.

NEXTDC has reported a robust first half of FY26, with strong revenue and earnings growth underpinned by a surging forward order book and expanded capital expenditure plans.

SciDev Limited posted a $2.14 million loss for the half-year ending December 2025, impacted by restructuring costs and a failed acquisition. Despite a 4% revenue dip, the company secured a major $19.5 million contract and maintains a strong balance sheet.

FINEOS Corporation Holdings Plc reported a modest revenue increase for 2025 but swung to a significant net loss, raising questions about its financial trajectory.

Scentre Group reported robust 2025 results with a 4.9% rise in Funds From Operations and record customer visitation, while progressing key sustainability and growth initiatives.

Scentre Group has reported a robust 2025 financial year with Funds From Operations rising 4.9% and distributions up 3.4%, underpinned by record occupancy and strong customer engagement. The Group also advanced its sustainability agenda, exceeding interim net zero targets and progressing major redevelopment projects.

Ingenia Communities reports a steady first half of FY26, maintaining full-year guidance at the top of its range, driven by accelerating development settlements and growth across rental and holiday segments.

Anax Metals has released an updated Definitive Feasibility Study for its Whim Creek Copper Project, confirming robust economics with a pre-tax NPV of A$501 million and an IRR of 98%, underpinned by a 10-year mine life and rapid payback.

Radiopharm Theranostics has initiated dosing in its Phase 1/2a clinical trial of BetaBart, a novel radiotherapeutic developed with MD Anderson Cancer Center, targeting aggressive solid tumors.

Abacus Group has reported a strong turnaround with a $47.6 million net profit for the half-year to December 2025, maintaining steady funds from operations and declaring a consistent interim distribution. The group is also exploring internalising management of its key joint venture, Abacus Storage King.